It regulates markers of inflammation by downregulating pro-inflammatory cytokines IL-1β, IL-6, and IL-8; TNF-α; and matrix metalloproteinase (MMP)-2, MMP-9, MMP-3, and MMP-13 in both in vivo and in vitro IBD models [39]. Here, CXCL8 is linked to inflammatory bowel disease.